Latest Breaking News On - Tscan therapeutics inc - Page 2 : comparemela.com

TScan Therapeutics (NASDAQ:TCRX) Reaches New 1-Year High at $9 55

TScan Therapeutics, Inc. (NASDAQ:TCRX – Get Free Report)’s share price hit a new 52-week high during trading on Tuesday . The company traded as high as $9.55 and last traded at $9.51, with a volume of 161078 shares traded. The stock had previously closed at $9.19. Wall Street Analysts Forecast Growth A number of brokerages […]

United statesNeedham companyCannon global investment managementLetko brosseau associates incTscan therapeutics incGet free reportTherapeutics stockFire capitalGlobal investment managementTherapeutics daily

Needham & Company LLC Reaffirms Buy Rating for TScan Therapeutics (NASDAQ:TCRX)

Needham & Company LLC reiterated their buy rating on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a report issued on Monday, MarketBeat Ratings reports. They currently have a $11.00 price target on the stock. TCRX has been the topic of a number of other reports. Wedbush reissued an outperform rating and issued a […]

United statesTscan therapeutics company profileCannon global investment managementLetko brosseau associates incNeedham companyTscan therapeutics incFree reportMarketbeat ratingsTherapeutics trading downGet free reportFire capitalGlobal investment managementTherapeutics companyTherapeutics daily

TScan Therapeutics (TCRX) Buy Rating Reiterated at HC Wainwright

TScan Therapeutics (TCRX) Buy Rating Reiterated at HC Wainwright
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesTscan therapeutics incVanguard group incNeedham companyCannon global investment managementLetko brosseau associates incFree reportGet free reportFire capitalGlobal investment managementTherapeutics daily

TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesGavin macbeathMaghan meyersHeather savelleAmerican society of clinical oncologyAmerican society of geneTscan therapeutics incAmerican association for cancer researchHeme malignancies programSolid tumor programGlobe newswire tscan therapeutics incSecurities exchangeChief executiveClinical oncologyAnnual meetingCell therapy

Key Takeaways From TScan Therapeutics Analyst Ratings - TScan Therapeutics (NASDAQ:TCRX)

Key Takeaways From TScan Therapeutics Analyst Ratings - TScan Therapeutics (NASDAQ:TCRX)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Health careTscan therapeutics incTscan therapeutics financial healthDown analyst ratingsTherapeutics incCapitalization highlights